Qualitis SA, is a Full-Service Clinical Research and Medical Consulting CRO Company, which is recently acquired by Optimapharm Group, Qualitis is offering a comprehensive portfolio of clinical development and medical consulting services to the Pharmaceutical, Biotechnology and Medical Device industries.

Through a commitment to a Company culture of superior quality service, integrity and innovation, Qualitis focuses on exceeding its customers particular needs and expectations.

Qualitis Team possesses an in-depth and long-term experience and expertise in both clinical research and medical-marketing environment and is strongly dedicated in constant learning and continuous improvement driven to create added value for our customers and become an integral part of their business success.

With a strong focus on people and standards, Qualitis has built upon the 3 milestones of business success: Quality, Commitment and Customer Trust.

Our specialty areas include but are not limited to the following:
    -Cardiovascular diseases
    -Neurology & Psychiatry
    -Pulmonary/Respiratory
    -Genitourinary
    -Gastroenterology
    -Oncology
    -Orthopedics
    -Pediatrics
    -Biotechnology
    -Allergy/Immunology
    -Dermatology
    -Virology
    -Endocrinology
    -Hematology
    -Ophthalmology

Areas of Operation-Projects Portfolio:
    -Phase II-IV Clinical Trials
    -Medical Device Studies
    -Non-Interventional Studies
    -Pharmacovigilance Studies
    -IIS (Investigator Initiated Studies)
    -Epidemiological Studies
    -Market Surveys

Customers Profile:
    -Pharmaceutical Companies
    -Biotechnology Companies
    -Medical Devices Companies
    -Academic Research Institutes & Hospitals
    -International CROs

Contact Details: E-mail: info@qualitis.gr	
                        Telephone: +30 210-7797750
                        Fax: 	        +30 210-7470441

Biotechnology

Life Sciences

Medical Devices

Pharmaceutical

Qualitis SA - now part of Optimapharm Group

Org chart

Similar companies